21 October 2020 — ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical development programme. In the midst of the global pandemic, the analysis found
0 Comments
Epidemiologist Dr. Ali Mokdad is advising people across the U.S. “to be very careful” and ” to change our behaviors” as the nation heads toward winter, the worst season for viral transmission. Mokdad’s research estimates America could see more than 500,000 total deaths from Covid-19 by the end of February, more than double the current
0 Comments
Reviewed by Emily Henderson, B.Sc.Oct 23 2020 With nearly half of the world’s population at risk for life-threatening malaria infections, University of Maryland School of Medicine (UMSOM) researchers and their colleagues identified an important public health measure to control the disease. Use of preventive antimalarial treatments reduces by half the number of malaria infections among
0 Comments
Adding nutritional supplements, and protein in particular, to the diet of patients on hemodialysis didn’t seem to bolster their mortality rates, a pragmatic trial found. In a cluster-randomized clinical trial of over 10,000 patients on hemodialysis, patients on an intensive oral nutritional supplement protocol had similar mortality rates compared with those on standard care (hazard
0 Comments
How long immunity lasts after a COVID-19, or SARS-CoV-2, infection is something that many studies are trying to determine. But it’s a question that may not be answered for some time, William Moss, MD, told Medical Daily. “[Since] we’re only 10 months into the pandemic … we still have a lot to learn, particularly about
0 Comments
For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined adverse renal outcomes and in combined adverse cardiovascular outcomes in the pivotal FIDELIO-DKD trial. And the safety results showed a good level of tolerability. The rate of hyperkalemia was higher
0 Comments
It used to be that if you saw someone speaking aloud while alone in a room, you’d wonder what was up. But these days, people have gotten used to talking to a disembodied voice that lives in their house. No, it’s not a ghost, but an artificial intelligence (AI) that includes systems like Google Home, Amazon’s Alexa
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Last spring, when Cliff Willmeng, RN, was working at United Hospital in St. Paul, Minnesota, he’d take off his personal protective equipment (PPE) in the same hallway where children were transported from ambulances to the neighboring Children’s Hospital emergency department. Stretchers
0 Comments
The United States could see “staggering” numbers of coronavirus deaths in the coming months as infection rates increase during the colder months, Dr. Scott Gottlieb told CNBC’s “Closing Bell” on Friday. There were 916 deaths from Covid-19 in the U.S. on Friday, according to data compiled by the Covid Tracking Project, an independent volunteer organization launched
0 Comments
Reviewed by Emily Henderson, B.Sc.Oct 23 2020 The results of a new clinical trial, published today in the New England Journal of Medicine, show that dexamethasone- a glucocorticoid used to treat many conditions, including rheumatic problems and severe COVID-19- can boost survival of premature babies when given to pregnant women at risk of preterm birth
0 Comments
Results from a preliminary study showed novel voice and breath analysis using a smartphone app to be a useful measure of lung function, and researchers say the technique may prove to be a valuable tool for identifying and monitoring respiratory disease. Automated voice and breath analysis was found to have value for predicting lung function,
0 Comments
Please be advised that this video contains graphic footage of surgery. This video demonstrates a Sistrunk Procedure in a child with a thyroglossal duct cyst performed by Dr. Karthik Balakrishnan. Chapter Authors: Jason H. Barnes, M.D. Karthik Balakrishnan, M.D. Series Editors: Andrew J. Goates, M.D., Matthew L. Carlson, M.D. To learn more about the Department
0 Comments
Fast detection of people infected with SARS-CoV-2, the virus that causes COVID-19, is key in managing the pandemic and preventing future outbreaks. Currently, the gold standard in testing is the RT-PCR test. But this test can take time to show results and is very expensive, especially for low-income nations. Researchers at the University of Edinburgh
0 Comments
The FDA has approved the drug known as remdesivir for the treatment of COVID-19.  In a statement released earlier this evening, the Food and Drug Administration said that remdesivir is allowed for patients 12 and over who weigh about 88 pounds. Remdesivir is only permitted for use in hospitals or other medical care settings that provide
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Researchers and several medical groups on Thursday pressed for changes to the US Food and Drug Administration’s (FDA) current plans for deciding how to eventually clear vaccines for COVID-19, arguing tougher standards would help bolster confidence in these critical medicines. The
0 Comments
FDA Approves Veklury (remdesivir) for the Treatment of COVID-19 FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 22, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication
0 Comments
The FDA took the unusual step Thursday in opening to the public a routine meeting with an advisory group that’s weighing in on approving the coronavirus vaccine as the agency battles public concerns about its safety as well as political pressure from President Donald Trump to approve it before the Nov. 3 election. The Vaccines
0 Comments
Reviewed by Emily Henderson, B.Sc.Oct 22 2020 New questions are at the forefront as a study published in the Journal of Clinical Microbiology from nine children’s hospitals finds that most asymptomatic children who tested positive for COVID-19 had relatively low levels of the virus compared to symptomatic children. The authors caution that the reason for
0 Comments
Patients with cancer and COVID-19 have a higher risk of severe disease and mortality, researchers reported. Of 89 cancer patients admitted to the intensive care unit (ICU) due to COVID-19, 32 died, a mortality rate of 36%, reported Michael Dang, MD, a critical care fellow at Memorial Sloan Kettering Cancer Center in New York City,
0 Comments
The nation’s racial upheaval, particularly vis-a-vis law enforcement, has shown us the value of the skill of de-escalation. A situation arises, and several outcomes are possible, although some are clearly preferred. The specific technique and approach utilized may determine the end result. A range of options is often available. What can make these situations so
0 Comments
The US Food and Drug Administration (FDA) Thursday approved remdesivir (Veklury) today as a treatment for hospitalized COVID-19 patients age 12 and, making is the drug the first and only approved treatment for COVID-19 in the United States, according to a release from manufacturer Gilead Sciences. The FDA’s initial Emergency Use Authorization (EUA) of the
0 Comments
With all the things that have happened this summer, it isn’t surprising that people may have missed the marijuana headlines. Over the past few months, there have been new regulations, lawsuits, state laws and celebrity endorsements of marijuana products.  Celebrity support For starters, actress Jane Fonda and entrepreneur Martha Stewart have both publicly backed CBD
0 Comments